Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

Bellicum offloads cell therapy plant in switch to outsourced production

Bellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement.

BioIVT in deal with upcyte on liver cells for in-vitro research

BioIVT taps into the advantages of hepatic cells for toxicology evaluations and screening studies, securing exclusive distribution agreement with upcyte.

New CDMO plans $1.1bn cell and gene therapy plant

A newly founded CDMO has outlined plans to invest $1.1bn to become the world’s biggest cell and gene therapy service provider.

CRO Novotech invests in Algernon, lands deal to run trial

Novotech set to invest in Algernon Pharmaceuticals after landing contract to run Phase II clinical trial.

PharSafer adopts Oracle’s cloud solution for pharmacovigilance

The CRO will utilize the platform to provide clinical and post-marketing drug safety services to clients.

Global Industry News

Hot Topics

Spotlight

White males overrepresented in clinical trials for first-time cancer treatment

EMA welcomes Court of Justice transparency finding

WCG continues acquisitive streak with biostatistical consultancy buyout

Boom in number of UK cell and gene therapy clinical trials

Reporting of clinical trial results is ‘poor and not improving’

Products

Webinars

On-demand webinars

Featured Suppliers

All suppliers

Ajinomoto Bio-Pharma Services

Baxter BioPharma Solutions

BBK Worldwide

Cambrex

Covance Inc

Frontage Laboratories

Marken

PRA Health Sciences

R-Pharm Germany GmbH

Synteract: Bringing Clinical Trials to Life

World Courier

Zymewire